|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Kymera Therapeutics, Inc. (KYMR) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
62,339,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Kymera Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. Co.'s proprietary targeted protein degradation platform, which Co. refers to as Pegasus™, allows Co. to discover selective small molecule protein degraders with activity against disease-causing proteins throughout the body. Co. has utilized its Pegasus™ platform to design protein degraders focused in the areas of immunology-inflammation and oncology, and Co. continues to apply its platform's capabilities to additional therapeutic areas.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
414,105 |
1,300,163 |
| Total Buy Value |
$0 |
$0 |
$5,301,325 |
$25,027,880 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
8 |
| Total Shares Sold |
846,935 |
906,367 |
906,367 |
2,944,621 |
| Total Sell Value |
$35,475,904 |
$37,488,861 |
$37,488,861 |
$99,885,268 |
| Total People Sold |
5 |
6 |
6 |
7 |
| Total Sell Transactions |
16 |
19 |
19 |
49 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2021-03-11 |
4 |
AS |
$60.07 |
$108,432 |
D/D |
(1,805) |
0 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2021-03-11 |
4 |
OE |
$2.08 |
$3,754 |
D/D |
1,805 |
1,805 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-03-11 |
4 |
AS |
$60.05 |
$281,939 |
D/D |
(4,695) |
45,052 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-03-11 |
4 |
OE |
$1.31 |
$2,882 |
D/D |
2,200 |
49,747 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2021-03-08 |
4 |
AS |
$50.46 |
$506,470 |
D/D |
(10,000) |
0 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2021-03-08 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
10,000 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2021-03-03 |
4 |
AS |
$44.12 |
$895,634 |
D/D |
(20,000) |
0 |
|
- |
|
| Jacobs Bruce N. |
Chief Financial Officer |
• – – |
2021-03-03 |
4 |
OE |
$2.08 |
$41,600 |
D/D |
20,000 |
20,000 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-02-24 |
4 |
AS |
$50.91 |
$441,671 |
D/D |
(8,675) |
47,547 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-02-23 |
4 |
AS |
$49.65 |
$957,554 |
D/D |
(19,285) |
56,222 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-02-22 |
4 |
AS |
$52.63 |
$479,130 |
D/D |
(9,104) |
75,507 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-02-19 |
4 |
AS |
$55.09 |
$489,559 |
D/D |
(8,887) |
84,611 |
|
- |
|
| Atlas Venture Fund X, L.p. |
10% Owner |
– – • |
2021-02-18 |
4 |
AS |
$0.00 |
$0 |
D/D |
(1,063,351) |
6,885,631 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-02-18 |
4 |
AS |
$55.94 |
$363,540 |
D/D |
(6,499) |
93,498 |
|
- |
|
| Gollob Jared |
Chief Medical Officer |
• – – |
2021-02-17 |
4 |
AS |
$58.39 |
$440,836 |
D/D |
(7,550) |
99,997 |
|
- |
|
| Wellington Biomedical Innovation Master Investors |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
959,211 |
959,211 |
|
- |
|
| Booth Bruce |
Director |
– • – |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
I/I |
8,309,270 |
1,112,686 |
|
- |
|
| Atlas Venture Opportunity Fund I, L.p. |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,112,686 |
1,112,686 |
|
- |
|
| Atlas Venture Opportunity Fund I, L.p. |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,196,584 |
7,948,982 |
|
- |
|
| Hall Steven Edward |
Director |
– • – |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
I/I |
2,192,249 |
2,192,249 |
|
- |
|
| Green Jeremy |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,630,660 |
1,630,660 |
|
- |
|
| Alexandria Venture Investments, Llc |
10% Owner |
– – • |
2020-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
467,932 |
467,932 |
|
- |
|
| Lampert Mark N |
See Explanation of Responses |
– – – |
2020-08-21 |
4 |
A |
$20.00 |
$19,573,860 |
D/D |
978,693 |
181,081 |
|
- |
|
| Lampert Mark N |
See Explanation of Responses |
– – – |
2020-08-21 |
4 |
A |
$0.00 |
$0 |
D/D |
1,578,804 |
113,290 |
|
- |
|
| Booth Bruce |
Director |
– • – |
2020-08-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
752,398 |
|
- |
|
204 Records found
|
|
Page 8 of 9 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
